Totally agree. Brian's been good in print in describing things, so I found it odd how terrible he was in the interview. I actually reduced my holdings after watching it, and more when they decided to give it a NR.
I had a lot of NMUS stock, so I decided to reduce it. I still have what I consider a large position, and still believe there's great promise. I just wasn't as comfortable if I lost half the value as I was pre-GWPH approval. Hopefully we will see the animal studies soon, and a clear path to clinical trials emerge by end of year or early next.
News 
Market Data 
Discover 
